{
    "2021-10-09": [
        [
            {
                "time": "",
                "original_text": "赛诺菲退出mRNA新冠疫苗研究 沃森生物静待三期临床结果",
                "features": {
                    "keywords": [
                        "赛诺菲",
                        "mRNA",
                        "新冠疫苗",
                        "沃森生物",
                        "三期临床"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "新冠疫苗概念股受冲击 默沙东新冠口服药物的冲击不宜高估",
                "features": {
                    "keywords": [
                        "新冠疫苗",
                        "概念股",
                        "默沙东",
                        "新冠口服药物"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药",
                        "制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}